Single-cell RNA sequencing (scRNA-seq) has highlighted the important role of intercellular heterogeneity in phenotype variability in both health and disease SLAM-seq 3 involves briefly exposing cells to the nucleoside analogue 4-thiouridine (4sU). 4sU is incorporated into new RNA during transcription and converted to a cytosine analogue using iodoacetamide (IAA) before RNA sequencing. Sequencing reads originating from new RNA can be identified within the pool of total RNA reads on the basis of characteristic U-to-C conversions. We applied the SLAM-seq technique to resolve the onset of lytic mouse cytomegalovirus (CMV) infection at the single-cell level. After optimization for single-cell sequencing (scSLAM-seq) (Fig. 1, Supplementary Methods) , we performed scSLAM-seq on 107 single mouse fibroblast cells and in parallel analysed global transcriptional changes of matched, larger (1 × 10 5
) populations of cells (n = 2) using (bulk) SLAM-seq. After quality filtering for cells with more than 2,500 detectable genes (Extended Data  Fig. 1a) , the remaining samples (49 CMV-infected, 45 uninfected cells) displayed all the characteristics of high-quality scSLAM-seq libraries (Extended Data Fig. 1b) , including U-to-C conversion rates of between 4% and 6% (Extended Data Fig. 1c, d ). Incorporation of 4sU is thus both efficient and uniform at the single-cell level.
Owing to rates of 4sU incorporation of about 1 in 50-200 nucleotides, up to 50% of all SLAM-seq reads that originate from new RNA may not contain U-to-C conversions. To overcome this problem, we developed 'globally refined analysis of newly transcribed RNA and decay rates using SLAM-seq' (GRAND-SLAM)-a Bayesian method to compute the ratio of new to total RNA (NTR) in a fully quantitative manner including credible intervals 4 ( Fig. 1 ). Here we report GRAND-SLAM 2.0 for the parallel analysis of hundreds of SLAM-seq libraries derived from single cells. The accuracy of quantification is further improved by analysing long reads (150 nucleotides) in paired-end mode (see Supplementary Methods), which allows 4sU conversions to be reliably distinguished from sequencing errors within the overlapping sequences (Extended Data Fig. 1c, d ). We obtained accurate measurements (90% credible interval < 0.2) for thousands of genes per cell, thereby approaching the overall sensitivity of scRNA-seq (Extended Data Recent findings reported that intronic reads from scRNA-seq data can be used to estimate time derivatives of gene expression in individual cells termed 'RNA velocities' 5 . These indicate the future trajectory of individual cells in low-dimensional projections of gene-expression space. However, infected cells could not be separated from uninfected cells by an unbiased PCA computed on the respective RNA velocities, or on the expression profiles projected into the future using the velocities, or directly on intron/exon ratios (Extended Data Fig. 3a) . To compare scSLAM-seq directly with RNA velocities computed for a larger population of cells, we performed 10x Genomics Chromium droplet-based scRNA-seq on hundreds of uninfected (n = 793) and CMV-infected (n = 353) cells using the same experimental conditions. Although PCA on mature transcripts (exonic reads only) did not separate uninfected and infected cells, the distinction was possible using intron/exon ratios (Extended Data Fig. 3b ). However, no meaningful directionalities in the RNA velocities of both the scSLAM-seq and 10x data were observed (Fig. 2b) . We used new and total RNA levels obtained by scSLAM-seq to replace intronic and exonic read levels and determine 'NTR velocities' . Notably, these further discriminated infected from non-infected cells (Fig. 2c) .
To compare NTRs and RNA velocity directly, we asked which of them could best predict whether a gene was upregulated or downregulated in large cell populations. Although this was possible to some extent using RNA velocities computed from dozens or hundreds of cells in scSLAM-seq or 10x data, respectively (area under receiver operating characteristic curve (AUC) values of 0.68 and 0.74), they were Letter reSeArCH outperformed by using NTRs (AUC > 0.94) (Fig. 2d, Extended Data  Fig. 3c ). Moreover, NTRs could be determined for substantially more regulated genes (n = 583) than velocities (n = 131 and n = 295, from scSLAM-seq and 10x data, respectively). NTRs and RNA velocities thus convey different-but complementary-information (Extended Data Fig. 3d ), and can be merged into NTR velocities to predict the future state of a cell more reliably.
A fundamental question in virology is why the infection of one cell results in extensive lytic virus replication whereas the infection of a second cell does not. At 2 h.p.i., CMV infection in most cells has already progressed from the 'immediate-early' (restricted to a few genes) to the 'early' phase of infection, in which most viral genes are already transcribed. Although most viral transcripts in all cells were new, we also observed substantial amounts of old RNAs of some viral genes (Extended Data Fig. 4 ). This represents virion-associated RNA that is delivered to the infected cell by the incoming virus particles Fig. 4 ) was much lower than in the other cells, which indicates that these cells were not less permissive to CMV infection but instead received a much lower dose of virus. On the basis of cell-cycle signature genes, the cell-cycle state both at the beginning and at the end of 4sU metabolic labelling can be inferred from old and total RNA, respectively, thereby providing cell-cycle trajectories 7 ( Fig. 2e ). Although lytic infection was initiated at all cell-cycle stages, cells infected during G1 phase resulted in significantly stronger viral gene expression and cell-cycle disruption (P < 0.05; Extended Data Fig. 5d , e). This increased the explained variance in new viral gene expression to 59% (Fig. 2f) . The efficiency by which lytic viral gene expression is initiated at the single-cell level in fibroblasts is thus well explained by the interaction of the dose of infection and cell cycle.
To assess the effects of CMV infection on cellular gene expression, we identified differentially expressed genes between CMV-infected and uninfected single cells in total, new and old RNA using single-cell two-phase testing procedure (SC2P) 8 (Supplementary Table 2 ). Most (more than 60%) of the downregulated (61 out of 87) and upregulated (188 out of 309) genes could be uncovered only by specifically considering new RNA (Fig. 3a) . Bimodality of gene expression is a well-described feature in single cells 8, 9 . A bimodally expressed gene is undetectable in a subpopulation of cells but expressed in others. scSLAM-seq directly visualizes whether the promoter of a given gene in a cell was 'on' within the studied time frame. Notably, we found that most CMV-induced changes in new RNA are much more consistent with on-off dynamics than with upregulation or downregulation (Fig. 3b, c) .
CMV infection induces a strong type I interferon (IFN) and NF-κB response during the first two hours of infection 10, 11 . Gene set analysis 12 from predicted transcription factor targets 13 and Gene Ontology terms demonstrated that the activation of both IFN and NF-κB was highly virus-dose dependent. However, although IFN activation was limited to about half of the infected cells, NF-κB activation occurred in most CMV-infected cells (Fig. 3d, Extended Data Fig. 5f , Supplementary Tables 3, 4). Virus dose-dependent activation of NF-κB in all cells is consistent with M45 tegument protein-mediated activation of NF-κB at or upstream of the IKK kinase complex 11 . By contrast, IFN responses require the detection of pathogen-associated molecular patterns 14 , are subject to autocrine and paracrine signalling, and may thus show greater variability between individual cells 15 . To perform a morefocused analysis, we defined both NF-κB-and IFN-responsive gene sets specific to CMV infection on the basis of previously published data on NF-κB induction 16 and IFN treatment 2 using our bulk SLAM-seq data (Supplementary Table 5 ). The magnitudes of the IFN (Fig. 3e) and NF-κB (Fig. 3f) responses varied markedly between individual cells but both were highly correlated with viral gene expression (Spearman's ρ > 0.52, P < 3 × 10 −4 ) (Extended Data Fig. 5g, h ). Most NF-κB-and IFN-inducible gene expression thus arises in the most-strongly infected cells, with the weakest responses being induced in cells infected during S phase (Extended Data Fig. 5i, j) .
Transcriptional activity at the single-cell level is not a continual process but consists of intermittent bursts of transcription separated by minutes to hours of transcriptional inactivity, indicative of temporarily non-permissive promoters 17, 18 . We reasoned that such bursting kinetics of a gene should be detectable by scSLAM-seq. To assess bursting kinetics globally, we defined gene-wise burst scores (B-scores) as the standard deviation of the NTR distribution from all uninfected cells in which RNA of the respective gene could be reliably quantified (90% credible interval of the NTR < 0.2; Supplementary Table 6 ; n = 5,540). B-scores obtained from two independent biological replicates were highly correlated (R = 0.74) (Extended Data Fig. 6a) . In some cases, extreme B-scores close to 0.5 corresponded to genes with only a single or very few mRNA molecules (either new or old) detected in each cell (Extended Data Fig. 6b) .
Current scRNA-seq protocols either provide unique molecular identifiers (UMIs) to estimate the number of captured mRNA molecules and are strand-specific but only clone transcript ends (for example, 10x Genomics Chromium scRNA-seq), or provide full-length mRNAs but no UMIs and lose strand-specificity (for example, Smart-seq2 19 ). Our Smart-seq-based scSLAM-seq approach-at least in partencompasses all three features. The random incorporation of 4sU 
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into mRNA molecules provides nucleotide conversion-based unique molecular identifiers (nUMIs), which enabled us to estimate a lower bound of the number of new mRNA molecules sampled per cell and gene, and-by extrapolation (enUMIs)-also of old mRNAs (Extended Data Figs. 6c-h, 7) . On the basis of these conservative estimates of the number of sampled mRNAs, we found that more than 30% (1,718 out of 5,540; adjusted P < 0.01, χ 2 test) of all detectable genes had greater variance (B-score) than expected from sampling (see Fig. 4a for examples). There was only a negligible correlation of the B-score with expression levels (Extended Data Fig. 8a) . Moreover, the observed heterogeneity in the NTR did not result from cell-cycle-dependent differences (Extended Data Fig. 8b-e ) but was associated with mRNA half-life (Extended Data Fig. 8f) .
Unbiased Gene Ontology overrepresentation analysis revealed high gene B-scores to be associated with functional categories such as protein phosphorylation and ubiquitination (Supplementary Table 7 ). Promoter analyses identified six motifs that were significantly enriched for either low (TATA box motif) or high (CG-rich and purine-rich motifs) (Extended Data Fig. 9; Supplementary Table 8 ) B-scores. Correctly placed TATA boxes were most highly enriched (P < 10 −8 ), consistent with promoters of the TATA box driving frequent transcriptional bursts on a timescale of minutes 20 . No association with other core promoter motifs was observed (Fig. 4b) . The CG-rich motifs could either correspond to binding sites of specific transcription factors that exhibit an oscillatory activation pattern or reflect CpG-rich regions within the respective promoters. More than 50% of mammalian transcription initiates from promoters close to CpG islands (CGI promoters), which represent CpG-rich regions of dozens to hundreds of nucleotides. Hypermethylation of CpG islands is an epigenetic control mechanism of gene silencing 21 . Bisulfite sequencing data from mouse fibroblasts 22 revealed significant correlation of methylated CGI promoters with low B-scores, whereas methylated non-CGI promoters tended to exhibit high B-scores (Fig. 4c) . The same was also observed for TATA-box-containing promoters (Fig. 4d) . We confirmed these results by repeating the analyses for the 1,718 genes with significant B-scores (Extended Data Fig. 10a ) and on the top 50% most-strongly expressed genes (Extended Data Fig. 10b ). Although we cannot fully exclude that allelic differences in transcriptional activity and karyotype complexity of the cell line used here account for some of the observed effects 23 , this does not explain the strong correlation of B-scores to promoter-intrinsic features. We propose a model in which DNA methylation within gene promoters is involved in the transient element; MTE, motif 10 element; TCT, polypyrimidine initiator element; XCPE1 and XCPE2, X core promoter element 1 and 2, respectively. c, Bscore distributions for CpG island (CGI) and non-CpG island (non-CGI) promoters stratified by DNA methylation status in bisulfite sequencing experiments. Only promoters without TATA boxes were considered. P values for differences of scores in strata are indicated (two-sided Wilcoxon rank-sum test, n = 2 replicates, 45 cells). Box plots denote the median (centre line) and interquartile range (box), with whiskers extending to three times the interquartile range. d, As in c but considering only TATA-box promoters. e, B-scores for each gene are scattered against the coefficient of variation (CV) of total RNA across cells. Genes were stratified according to their RNA half-life (t 1/2 ). The percentage of non-drop-out cells is indicated.
regulation of promoter activity on the timescale of hours by temporarily rendering gene promoters non-permissive. Finally, B-scores were highly correlated with the observed heterogeneity in the transcriptomes of individual cells (Fig. 4e) . Gene promoter-specific features thus represent a major contributor to intercellular heterogeneity.
Metabolic labelling using 4sU is applicable to all major model organisms including vertebrates, insects, plants and yeast. The purine analogue 6-thioguanine (6sG) now also enables G-to-A conversions by oxidative-nucleophilic-aromatic substitution (TimeLapse-seq chemistry) 24 . Short, consecutive pulses of 4sU and 6sG followed by thiol-(SH)-mediated nucleoside conversions may enable two independent recordings of transcriptional activity in single cells. Finally, scSLAM-seq combined with CRISPR-based perturbations will greatly improve the sensitivity of the respective approaches to decipher the molecular mechanisms with major implications for developmental biology, infection and cancer.
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Extended Data Fig. 1 | scSLAM-seq quality controls . a, Total number of genes detected after scSLAM-seq across all four experimental conditions (uninfected and CMV-infected cells; two biological replicates) versus the total read counts per single cell. The horizontal line indicates a threshold below which cells were excluded from the analysis. b, Partition of reads devoted for host (cellular), viral, spike-in control (External RNA Controls Consortium (ERCC)) and mitochondrial genes (Mitoch) across all individual cells. c, Rates of nucleotide substitutions demonstrate efficient conversion rates in 4sU-treated single cells (4sU) compared with 4sU-naive cells (no4sU). This was true for reads originating from both cDNA strands (sense and antisense) as well as overlapping parts of the pairedend sequencing (overlap). d, As in c, zoomed into the range (y axis) 0 to 0.004. e, Number of genes per cell for which the NTR could be quantified with high precision (90% credible interval (CI) < 0.2) compared with the detected genes and reliably detected genes (TPM >10). f, Correlation between expression levels of bulk RNA-seq with the pooled scRNA-seq data for total, new and old RNA. Genes are coloured according to RNA half-life. Pearson's correlation coefficient (R) and the number of genes used (n) are indicated. g, Identification of highly variable genes (magenta) using ERCC spike-ins to model the technical noise applied to total RNA (1% false discovery rate). Squared coefficients of variation (CV 2 ) are plotted against the average normalized read counts for all cells that pass the quality-control filters. The solid pink line fits the average values for ERCC spike-ins (blue dots) 25 . The dashed line marks the expected position of genes with 50% biological coefficient of variation. h, PCA (the two first components are depicted) of highly variably genes including the viral transcripts (infected: n = 2 replicates, 49 cells; uninfected: n = 2 replicates, 45 cells). i, Correlation of the percentage of viral reads with the distance to uninfected cells in the first two principal components as measured by logistic regression for the PCA in f (n = 2 replicates, 49 cells). j, As in i, for the PCA in Fig. 2a (n = 2 replicates, 49 cells) . Fig. 3 | RNA and NTR velocities. a, PCA computed on velocity values, on expression values projected 1 h into the future using velocity and the intron/exon count ratio for the scSLAM-seq data using the same set of genes as in Fig. 2a The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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